SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-006834
Filing Date
2024-01-25
Accepted
2024-01-25 20:38:51
Documents
2
Period of Report
2024-01-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244073-6_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm244073-6_3seq1.xml 3 11900
2 EXHIBIT 24.1 tm244073d6_ex24-1.htm EX-24.1 8110
  Complete submission text file 0001104659-24-006834.txt   21496
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent Biopharma, Inc. (Issuer) CIK: 0001868279 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 18 CAMPUS BOULEVARD SUITE 100 NEWTOWN SQUARE PA 19073
Business Address
LaChapelle Robin (Reporting) CIK: 0002009136 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41929 | Film No.: 24563844